Joseph F. Sobanko, MD Anthony J. Taglienti, MD Anthony J. Wilson, MD David B. Sarwer, PhD David J. Margolis, MD, PhD Julia Dai, BA Ivona Percec, MD, PhD
Aesthetic Surgery Journal, Volume 35, Issue 8, 1 November 2015, Pages 1014–1020
Published: 02 June 2015
Abstract
Background
The demand for minimally invasive cosmetic procedures has continued to rise, yet few studies have examined this patient population.
Objectives
This study sought to define the demographics, social characteristics, and motivations of patients seeking minimally invasive facial cosmetic procedures.
Methods
A prospective, single-institution cohort study of 72 patients was conducted from 2011 through 2014 at an urban academic medical center. Patients were aged 25 through 70 years; presented for botulinum toxin or soft tissue filler injections; and completed demographic, informational, and psychometric questionnaires before treatment. Descriptive statistics were conducted using Stata statistical software.
Results
The average patient was 47.8 years old, was married, had children, was employed, possessed a college or advanced degree, and reported an above-average income. Most patients felt that the first signs of aging occurred around their eyes (74.6%), and a similar percentage expressed this area was the site most desired for rejuvenation. Almost one-third of patients experienced a “major life event” within the preceding year, nearly half had sought prior counseling from a mental health specialist, and 23.6% were being actively prescribed psychiatric medication at the time of treatment.
Conclusions
Patients undergoing injectable aesthetic treatments in an urban outpatient academic center were mostly employed, highly educated, affluent women who believed that their procedure would positively impact their appearance. A significant minority experienced a major life event within the past year, which an astute clinician should address during the initial patient consultation. This study helps to better understand the psychosocial factors characterizing this patient population.
Level of Evidence: 4